Johnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, months after a similar case brought by Gilead Sciences Inc.
In a complaint filed on April 7 and made public on Tuesday, J&J said it had learned of widespread counterfeiting through complaints from patients who received the wrong pills in their prescription bottle, and from the voluntary return of hundreds of bottles of counterfeit drugs from one of the defendants, distributor ProPharma Distribution LLC.
The company also said that distribution of counterfeit versions of its HIV pills had come to light through Gilead’s lawsuit. The drugs at issue include Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant.
…